ECCRINE CARCINOMA

This adverse event was reported 30 times

ECCRINE CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEMIGATINIB 1 0.0012
1 EVEROLIMUS TABLETS 5 0.0003
2 BLEOMYCIN SULFATE 3 0.0003
3 MITOMYCIN 1 0.0003
4 DACARBAZINE 2 0.0003
5 TACROLIMUS OINTMENT 0.1% 17 0.0001
6 TACROLIMUS EXTENDED-RELEASE CAPSULES 17 0.0001
7 TACROLIMUS 17 0.0001
8 AZATHIOPRINE 9 0.0001
9 EVEROLIMUS 5 0.0001
See all drugs enriched for association with ECCRINE CARCINOMA

ECCRINE CARCINOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Purine Antimetabolite [EPC] 9 0.0001
1 Provitamin D2 Compound [EPC] 1 0.0000
2 beta3-Adrenergic Agonist [EPC] 1 0.0000
3 Alkylating Drug [EPC] 4 0.0000
4 Kinase Inhibitor [EPC] 7 0.0000
5 Janus Kinase Inhibitor [EPC] 2 0.0000
6 Corticosteroid [EPC] 15 0.0000
7 Aromatase Inhibitor [EPC] 1 0.0000
8 Microtubule Inhibitor [EPC] 1 0.0000
9 Thiazide Diuretic [EPC] 1 0.0000
See all drug classes enriched for association with ECCRINE CARCINOMA